O'Neill Institute  |  September 5, 2019

Read the Publication

Hepatitis C (HCV) cases have increased three-and-a- half times from 2010-2016, primarily due to the increase in injection drug use as the United States grapples with the public health crisis of substance use disorder (SUD). Syringe services programs provide a broad range of harm reduction services and can improve the health of persons who inject drugs including reducing HCV transmission.

Read the Big Ideas here.

Related Projects

Hepatitis Policy Project